New research reveals potential path forward for glioblastoma treatment

The committee did not vote on Imfinzi’s approval in this indication, but the overall majority suggested that it should be approved. Credit: Inside Creative House

The FDA’s Pul­monary-Al­ler­gy Drugs Ad­vi­so­ry Com­mit­tee will meet Fri­day to dis­cuss Mer­ck’s ap­pli­ca­tion for its chron­ic cough oral drug gefapix­ant, with the agency say­ing the